Data Sharing, Clinical Trials, and Biomarkers in Precision Oncology: Challenges, Opportunities, and Programs at the Department of Veterans Affairs

Cancer genomic research reveals that a similar cancer clinical phenotype (e.g., non‐small cell lung cancer) can arise from various mutations in tumor DNA. Thus, organ of origin is not a definitive classification. Further, targeted therapy for cancer patients (precision oncology) capitalizes on knowl...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Clin Pharmacol Ther
Glavni autori: Fiore, LD, Brophy, MT, Ferguson, RE, Shannon, C, Turek, SJ, Pierce‐Murray, K, Ajjarapu, S, Huang, GD, Lee, CSE, Lavori, PW
Format: Artigo
Jezik:Inglês
Izdano: John Wiley and Sons Inc. 2017
Teme:
Perspectives
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5414893/
https://ncbi.nlm.nih.gov/pubmed/28182272
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cpt.660
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items